Clinical Trial Update: Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER). [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (TIGER) evaluating vitrectomy with subretinal tissue plasminogen activator and intravitreal gas for submacular hemorrhage in wet age-re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Submacular Hemorrhage

Drugs mentioned

• Intravitreal gas (gas tamponade; e.g., C3F8) (intravitreal gas)
• Tissue plasminogen activator (tPA) (tPA)

Snippet

Sponsor: King's College Hospital NHS Trust | Conditions: Eye Diseases, Macular Degeneration, Wet | Phase 3 | Status: RECRUITING